0.010858
0.000000
0.000000
0.000000
0.010858
0.000000
0.000000
0.000000
0.021552
0.00000
0.00000
0.00000
Mueller, T.
Buehner, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
92.100
92.100
46.400
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
247
360
372
10.1006/jmbi.1994.0144
7707380
Human interleukin-4 and variant R88Q: phasing X-ray diffraction data by molecular replacement using X-ray and nuclear magnetic resonance models.
1995
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
237
423
Aspects of Receptor Binding and Signalling of Interleukin-4 Investigated by Site-Directed Mutagenesis and NMR Spectroscopy
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
AREA DETECTOR
1991-10-31
SIEMENS-NICOLET X100
M
x-ray
1
1.5418
1.0
1.5418
14989.248
INTERLEUKIN-4
1
man
polymer
18.015
water
21
nat
water
IL-4, IL4
no
no
HKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLI
RFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
HKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLI
RFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
BLOOD
Escherichia
sample
T-LYMPHOCYTES
9606
Homo sapiens
562
Escherichia coli
RTSPRC109
3.28
62.52
repository
Initial release
Version format compliance
Version format compliance
1
0
1996-01-29
1
1
2008-03-24
1
2
2011-07-13
Y
1995-06-01
REL
REL
HOH
water
HOH
200
2
HOH
HOH
200
A
HOH
201
2
HOH
HOH
201
A
HOH
202
2
HOH
HOH
202
A
HOH
203
2
HOH
HOH
203
A
HOH
204
2
HOH
HOH
204
A
HOH
205
2
HOH
HOH
205
A
HOH
206
2
HOH
HOH
206
A
HOH
207
2
HOH
HOH
207
A
HOH
208
2
HOH
HOH
208
A
HOH
209
2
HOH
HOH
209
A
HOH
210
2
HOH
HOH
210
A
HOH
211
2
HOH
HOH
211
A
HOH
212
2
HOH
HOH
212
A
HOH
213
2
HOH
HOH
213
A
HOH
214
2
HOH
HOH
214
A
HOH
215
2
HOH
HOH
215
A
HOH
216
2
HOH
HOH
216
A
HOH
217
2
HOH
HOH
217
A
HOH
218
2
HOH
HOH
218
A
HOH
219
2
HOH
HOH
219
A
HOH
220
2
HOH
HOH
220
A
HIS
1
n
1
HIS
1
A
LYS
2
n
2
LYS
2
A
CYS
3
n
3
CYS
3
A
ASP
4
n
4
ASP
4
A
ILE
5
n
5
ILE
5
A
THR
6
n
6
THR
6
A
LEU
7
n
7
LEU
7
A
GLN
8
n
8
GLN
8
A
GLU
9
n
9
GLU
9
A
ILE
10
n
10
ILE
10
A
ILE
11
n
11
ILE
11
A
LYS
12
n
12
LYS
12
A
THR
13
n
13
THR
13
A
LEU
14
n
14
LEU
14
A
ASN
15
n
15
ASN
15
A
SER
16
n
16
SER
16
A
LEU
17
n
17
LEU
17
A
THR
18
n
18
THR
18
A
GLU
19
n
19
GLU
19
A
GLN
20
n
20
GLN
20
A
LYS
21
n
21
LYS
21
A
THR
22
n
22
THR
22
A
LEU
23
n
23
LEU
23
A
CYS
24
n
24
CYS
24
A
THR
25
n
25
THR
25
A
GLU
26
n
26
GLU
26
A
LEU
27
n
27
LEU
27
A
THR
28
n
28
THR
28
A
VAL
29
n
29
VAL
29
A
THR
30
n
30
THR
30
A
ASP
31
n
31
ASP
31
A
ILE
32
n
32
ILE
32
A
PHE
33
n
33
PHE
33
A
ALA
34
n
34
ALA
34
A
ALA
35
n
35
ALA
35
A
SER
36
n
36
SER
36
A
LYS
37
n
37
LYS
37
A
ASN
38
n
38
ASN
38
A
THR
39
n
39
THR
39
A
THR
40
n
40
THR
40
A
GLU
41
n
41
GLU
41
A
LYS
42
n
42
LYS
42
A
GLU
43
n
43
GLU
43
A
THR
44
n
44
THR
44
A
PHE
45
n
45
PHE
45
A
CYS
46
n
46
CYS
46
A
ARG
47
n
47
ARG
47
A
ALA
48
n
48
ALA
48
A
ALA
49
n
49
ALA
49
A
THR
50
n
50
THR
50
A
VAL
51
n
51
VAL
51
A
LEU
52
n
52
LEU
52
A
ARG
53
n
53
ARG
53
A
GLN
54
n
54
GLN
54
A
PHE
55
n
55
PHE
55
A
TYR
56
n
56
TYR
56
A
SER
57
n
57
SER
57
A
HIS
58
n
58
HIS
58
A
HIS
59
n
59
HIS
59
A
GLU
60
n
60
GLU
60
A
LYS
61
n
61
LYS
61
A
ASP
62
n
62
ASP
62
A
THR
63
n
63
THR
63
A
ARG
64
n
64
ARG
64
A
CYS
65
n
65
CYS
65
A
LEU
66
n
66
LEU
66
A
GLY
67
n
67
GLY
67
A
ALA
68
n
68
ALA
68
A
THR
69
n
69
THR
69
A
ALA
70
n
70
ALA
70
A
GLN
71
n
71
GLN
71
A
GLN
72
n
72
GLN
72
A
PHE
73
n
73
PHE
73
A
HIS
74
n
74
HIS
74
A
ARG
75
n
75
ARG
75
A
HIS
76
n
76
HIS
76
A
LYS
77
n
77
LYS
77
A
GLN
78
n
78
GLN
78
A
LEU
79
n
79
LEU
79
A
ILE
80
n
80
ILE
80
A
ARG
81
n
81
ARG
81
A
PHE
82
n
82
PHE
82
A
LEU
83
n
83
LEU
83
A
LYS
84
n
84
LYS
84
A
ARG
85
n
85
ARG
85
A
LEU
86
n
86
LEU
86
A
ASP
87
n
87
ASP
87
A
ARG
88
n
88
ARG
88
A
ASN
89
n
89
ASN
89
A
LEU
90
n
90
LEU
90
A
TRP
91
n
91
TRP
91
A
GLY
92
n
92
GLY
92
A
LEU
93
n
93
LEU
93
A
ALA
94
n
94
ALA
94
A
GLY
95
n
95
GLY
95
A
LEU
96
n
96
LEU
96
A
ASN
97
n
97
ASN
97
A
SER
98
n
98
SER
98
A
CYS
99
n
99
CYS
99
A
PRO
100
n
100
PRO
100
A
VAL
101
n
101
VAL
101
A
LYS
102
n
102
LYS
102
A
GLU
103
n
103
GLU
103
A
ALA
104
n
104
ALA
104
A
ASN
105
n
105
ASN
105
A
GLN
106
n
106
GLN
106
A
SER
107
n
107
SER
107
A
THR
108
n
108
THR
108
A
LEU
109
n
109
LEU
109
A
GLU
110
n
110
GLU
110
A
ASN
111
n
111
ASN
111
A
PHE
112
n
112
PHE
112
A
LEU
113
n
113
LEU
113
A
GLU
114
n
114
GLU
114
A
ARG
115
n
115
ARG
115
A
LEU
116
n
116
LEU
116
A
LYS
117
n
117
LYS
117
A
THR
118
n
118
THR
118
A
ILE
119
n
119
ILE
119
A
MET
120
n
120
MET
120
A
ARG
121
n
121
ARG
121
A
GLU
122
n
122
GLU
122
A
LYS
123
n
123
LYS
123
A
TYR
124
n
124
TYR
124
A
SER
125
n
125
SER
125
A
LYS
126
n
126
LYS
126
A
CYS
127
n
127
CYS
127
A
SER
128
n
128
SER
128
A
SER
129
n
129
SER
129
A
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
8_665
-y+1,-x+1,-z+1/2
crystal symmetry operation
92.1000000000
92.1000000000
23.2000000000
A
O
VAL
29
A
O
VAL
29
A
N
SER
107
A
N
SER
107
1
A
CYS
3
-98.24
45.76
1
A
ASP
31
-53.80
81.65
1
A
ASN
38
76.08
168.64
1
A
THR
39
-132.49
-91.69
1
A
THR
40
176.89
159.06
1
A
ASN
97
-152.25
13.61
1
A
SER
128
-136.11
-58.12
12.3
0.324
0.216
0.216
2.60
6.0
5640
10.0
94.4
1
0.15
2.60
6.0
21
1069
0
0
1048
0.014
1.137
2.02
2.55
26.7
1HIK
6211
0.077
1
4.0
94.
data collection
XENGEN
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
data reduction
XENGEN
phasing
X-PLOR
3.1
INTERLEUKIN-4
INTERLEUKIN-4 (WILD-TYPE)
1
N
N
2
N
N
A
THR
6
A
THR
6
HELX_P
A
LEU
17
A
LEU
17
5
1
12
A
GLU
41
A
GLU
41
HELX_P
A
HIS
59
A
HIS
59
1
2
19
A
ALA
70
A
ALA
70
HELX_P
A
ALA
94
A
ALA
94
1
3
25
A
LEU
109
A
LEU
109
HELX_P
A
LYS
126
A
LYS
126
1
4
18
disulf
2.029
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
127
A
SG
CYS
127
1_555
disulf
2.034
A
CYS
24
A
SG
CYS
24
1_555
A
CYS
65
A
SG
CYS
65
1_555
disulf
2.032
A
CYS
46
A
SG
CYS
46
1_555
A
CYS
99
A
SG
CYS
99
1_555
CYTOKINE
CYTOKINE
IL4_HUMAN
UNP
1
1
P05112
MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFY
SHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
25
153
1HIK
1
129
P05112
A
1
1
129
2
anti-parallel
A
THR
28
A
THR
28
A
THR
30
A
THR
30
A
GLN
106
A
GLN
106
A
THR
108
A
THR
108
92
P 41 21 2